These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 30765880)
1. Characteristics of mismatch repair deficiency in sarcomas. Doyle LA; Nowak JA; Nathenson MJ; Thornton K; Wagner AJ; Johnson JM; Albrayak A; George S; Sholl LM Mod Pathol; 2019 Jul; 32(7):977-987. PubMed ID: 30765880 [TBL] [Abstract][Full Text] [Related]
2. PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated Tumors. Sloan EA; Ring KL; Willis BC; Modesitt SC; Mills AM Am J Surg Pathol; 2017 Mar; 41(3):326-333. PubMed ID: 27984238 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of recurrent oncogenic fusion in mismatch repair-deficient colorectal carcinoma with hypermethylated MLH1 and wild-type BRAF and KRAS. Wang J; Yi Y; Xiao Y; Dong L; Liang L; Teng L; Ying JM; Lu T; Liu Y; Guan Y; Pang J; Zhou L; Lu J; Zhang Z; Liu X; Liang X; Zeng X; Yi X; Zhou W; Xia X; Yang L; Zhang J; Kopetz S; Futreal PA; Wu H; Liang Z Mod Pathol; 2019 Jul; 32(7):1053-1064. PubMed ID: 30723297 [TBL] [Abstract][Full Text] [Related]
4. Combined Gemcitabine and Immune-Checkpoint Inhibition Conquers Anti-PD-L1 Resistance in Low-Immunogenic Mismatch Repair-Deficient Tumors. Salewski I; Henne J; Engster L; Schneider B; Lemcke H; Skorska A; Berlin P; Henze L; Junghanss C; Maletzki C Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206051 [TBL] [Abstract][Full Text] [Related]
5. High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriers. González-Acosta M; Marín F; Puliafito B; Bonifaci N; Fernández A; Navarro M; Salvador H; Balaguer F; Iglesias S; Velasco A; Grau Garces E; Moreno V; Gonzalez-Granado LI; Guerra-García P; Ayala R; Florkin B; Kratz C; Ripperger T; Rosenbaum T; Januszkiewicz-Lewandowska D; Azizi AA; Ragab I; Nathrath M; Pander HJ; Lobitz S; Suerink M; Dahan K; Imschweiler T; Demirsoy U; Brunet J; Lázaro C; Rueda D; Wimmer K; Capellá G; Pineda M J Med Genet; 2020 Apr; 57(4):269-273. PubMed ID: 31494577 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinicopathologic/molecular characteristics of mismatch repair-deficient colorectal cancer in the under-50-year-old Japanese population. Suzuki O; Eguchi H; Chika N; Sakimoto T; Ishibashi K; Kumamoto K; Tamaru JI; Tachikawa T; Akagi K; Arai T; Okazaki Y; Ishida H Surg Today; 2017 Sep; 47(9):1135-1146. PubMed ID: 28258479 [TBL] [Abstract][Full Text] [Related]
7. Frequency of mismatch repair protein deficiency and PD-L1 in high-grade gliomas in adolescents and young adults (AYA). Almuhaisen G; Alhalaseh Y; Mansour R; Abu-Shanab A; Al-Ghnimat S; Al-Hussaini M Brain Tumor Pathol; 2021 Jan; 38(1):14-22. PubMed ID: 32897465 [TBL] [Abstract][Full Text] [Related]
8. Colorectal carcinoma with double somatic mismatch repair gene inactivation: clinical and pathological characteristics and response to immune checkpoint blockade. Wang T; Lee LH; Vyas M; Zhang L; Ganesh K; Firat C; Segal NH; Desai A; Hechtman JF; Ntiamoah P; Weiser MR; Markowitz AJ; Vakiani E; Klimstra DS; Stadler ZK; Shia J Mod Pathol; 2019 Oct; 32(10):1551-1562. PubMed ID: 31175329 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents. Bodo S; Colas C; Buhard O; Collura A; Tinat J; Lavoine N; Guilloux A; Chalastanis A; Lafitte P; Coulet F; Buisine MP; Ilencikova D; Ruiz-Ponte C; Kinzel M; Grandjouan S; Brems H; Lejeune S; Blanché H; Wang Q; Caron O; Cabaret O; Svrcek M; Vidaud D; Parfait B; Verloes A; Knappe UJ; Soubrier F; Mortemousque I; Leis A; Auclair-Perrossier J; Frébourg T; Fléjou JF; Entz-Werle N; Leclerc J; Malka D; Cohen-Haguenauer O; Goldberg Y; Gerdes AM; Fedhila F; Mathieu-Dramard M; Hamelin R; Wafaa B; Gauthier-Villars M; Bourdeaut F; Sheridan E; Vasen H; Brugières L; Wimmer K; Muleris M; Duval A; Gastroenterology; 2015 Oct; 149(4):1017-29.e3. PubMed ID: 26116798 [TBL] [Abstract][Full Text] [Related]
10. Morphological, immunophenotypical and molecular features of hypermutation in colorectal carcinomas with mutations in DNA polymerase ε (POLE). Forgó E; Gomez AJ; Steiner D; Zehnder J; Longacre TA Histopathology; 2020 Feb; 76(3):366-374. PubMed ID: 31479159 [TBL] [Abstract][Full Text] [Related]
11. Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes. Moukarzel LA; Da Cruz Paula A; Ferrando L; Hoang T; Sebastiao APM; Pareja F; Park KJ; Jungbluth AA; Capella G; Pineda M; Levin JD; Abu-Rustum NR; Ellenson LH; Bel AV; Reis-Filho JS; Matias-Guiu X; Cadoo K; Stadler ZK; Weigelt B Mod Pathol; 2021 May; 34(5):994-1007. PubMed ID: 33328602 [TBL] [Abstract][Full Text] [Related]
12. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. Mensenkamp AR; Vogelaar IP; van Zelst-Stams WA; Goossens M; Ouchene H; Hendriks-Cornelissen SJ; Kwint MP; Hoogerbrugge N; Nagtegaal ID; Ligtenberg MJ Gastroenterology; 2014 Mar; 146(3):643-646.e8. PubMed ID: 24333619 [TBL] [Abstract][Full Text] [Related]
13. Lynch syndrome-associated ultra-hypermutated pediatric glioblastoma mimicking a constitutional mismatch repair deficiency syndrome. Yang C; Austin F; Richard H; Idowu M; Williamson V; Sabato F; Ferreira-Gonzalez A; Turner SA Cold Spring Harb Mol Case Stud; 2019 Oct; 5(5):. PubMed ID: 31604779 [TBL] [Abstract][Full Text] [Related]
14. Mismatch repair deficiency is implicated in carcinoma arising from ovarian teratoma. Cheung AH; Chow C; Yu MY; Law WW; Law PP; Choi PC; Kang W; To KF Pathology; 2019 Jan; 51(1):67-73. PubMed ID: 30502217 [TBL] [Abstract][Full Text] [Related]
15. Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomas. Liu S; Gӧnen M; Stadler ZK; Weiser MR; Hechtman JF; Vakiani E; Wang T; Vyas M; Joneja U; Al-Bayati M; Segal NH; Smith JJ; King S; Guercio S; Ntiamoah P; Markowitz AJ; Zhang L; Cercek A; Garcia-Aguilar J; Saltz LB; Diaz LA; Klimstra DS; Shia J Mod Pathol; 2019 Jan; 32(1):110-121. PubMed ID: 30166615 [TBL] [Abstract][Full Text] [Related]
16. Combined prognostic value of CD274 (PD-L1)/PDCDI (PD-1) expression and immune cell infiltration in colorectal cancer as per mismatch repair status. Ahtiainen M; Wirta EV; Kuopio T; Seppälä T; Rantala J; Mecklin JP; Böhm J Mod Pathol; 2019 Jun; 32(6):866-883. PubMed ID: 30723299 [TBL] [Abstract][Full Text] [Related]
17. Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells. Le Flahec G; Badic B; Guibourg B; Doucet L; Bail JP; Marcorelles P; Schick U; Uguen A Hum Pathol; 2018 Feb; 72():135-143. PubMed ID: 29208565 [TBL] [Abstract][Full Text] [Related]
18. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer. Carethers JM; Stoffel EM World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352 [TBL] [Abstract][Full Text] [Related]
19. Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas. Clendenning M; Huang A; Jayasekara H; Lorans M; Preston S; O'Callaghan N; Pope BJ; Macrae FA; Winship IM; Milne RL; Giles GG; English DR; Hopper JL; Win AK; Jenkins MA; Southey MC; Rosty C; Buchanan DD; Fam Cancer; 2018 Jan; 17(1):91-100. PubMed ID: 28616688 [TBL] [Abstract][Full Text] [Related]
20. DNA mismatch repair protein immunohistochemistry - an illustrated guide. Bateman AC Histopathology; 2021 Aug; 79(2):128-138. PubMed ID: 33829541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]